Literature DB >> 9622040

Thromboembolic complications several days after a single-dose administration of aspirin.

O Aguejouf1, E Belougne-Malfatti, F Doutremepuich, P Belon, C Doutremepuich.   

Abstract

The antithrombotic properties of acetyl salicylic acid (ASA) used at current doses are largely demonstrated. However, our previous study showed unexpected thrombotic potencies associated with the use of this drug. In this study we investigate the effect of aspirin on an experimental thrombosis induced by laser beams, according to its in vivo plasma concentration. Experiments were done on nine groups of seven Wistar male rats. The groups are defined by the delay between aspirin administration time and the laser-induced thrombosis time. Results from this study showed an enhancement of thromboembolic complications when thrombosis was induced 8 or 10 days after aspirin administration; the number of emboli and the duration of embolization are increased, compared to the control group. The prothrombotic properties of ASA demonstrated in this study, might limit its therapeutic benefit and might explain thromboembolic complications observed in some ASA-treated patients. These results also suggest a biological monitoring several days after aspirin administration to patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622040     DOI: 10.1016/s0049-3848(97)00302-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

Review 1.  Towards understanding molecular mechanisms of action of homeopathic drugs: an overview.

Authors:  Anisur Rahman Khuda-Bukhsh
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  Spontaneous Early Recanalization after Acute Innominate Artery Thromboembolic Occlusion Secondary to Abrupt Aspirin and Statin Discontinuation: A Case Report.

Authors:  C-K Tsai; J-T Lee; Y-C Wu; G-S Peng
Journal:  West Indian Med J       Date:  2014-07-02       Impact factor: 0.171

3.  Withdrawal of Antithrombotic Agents and the Risk of Stroke.

Authors:  Monica L Wagner; Jane C Khoury; Kathleen Alwell; Eric Rademacher; Daniel Woo; Matthew L Flaherty; Aaron M Anderson; Opeolu Adeoye; Simona Ferioli; Brett M Kissela; Dawn Kleindorfer; Joseph P Broderick
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-01-28       Impact factor: 2.136

4.  Thrombotic events associated to aspirin therapy.

Authors:  Christian Doutremepuich; Omar Aguejouf; Vanessa Desplat; Dominique Duprat; Francisco X Eizayaga
Journal:  Thrombosis       Date:  2011-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.